NEW YORK (GenomeWeb) – The American Association for Cancer Research today urged the US Food and Drug Administration to start actively regulating "high risk" lab developed tests that doctors are using to make decisions about how to treat their cancer patients.

In addition, the association's immediate past president Charles Sawyers was scheduled to provide testimony in a hearing being held today by a House of Representatives committee to provide Congress with a better picture of how LDTs are being used and the regulatory structures that affect them.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.

The New York Times reports that a number of companies and research institutes are pursuing gene therapies.

Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.

In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.